70 completed. 70 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 70 | Completed 70 |
| Phase 2 | 6 | Completed 6 |
Follow Ethanol: new trials by email Literature Review of Ethanol trials Research Report on Ethanol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults 5 mg Dronabinol (Marinol®) + Placebo Beverage, 10 mg Dronabinol (Marinol®) + Placebo Beverage, 5 mg Dronabinol (Marinol®) + Alcohol Beverage - Cannabis, Drug Effects, Driving Performance | Phase 1 | Completed | Food and Drug Administration (FDA) | 48 | 2025-12-29 | 2026-09-30 |
| A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol Tunodafil Hydrochloride Tablets, Placebo, Alcohol - Erectile Dysfunction | Phase 1 | Completed | Yangtze River Pharmaceutical Group Co., Ltd. | 22 | 2022-12-19 | 2023-08-04 |
| A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects TPN171H tablet plus alcohol, alcohol, TPN171H tablet - Alcohol, Phosphodiesterase Inhibitor | Phase 1 | Completed | Vigonvita Life Sciences | 19 | 2022-02-24 | 2022-05-23 |
| The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment Cannabis, Alcohol - Cannabis Intoxication, Alcohol Intoxication | Phase 1 | Completed | Johns Hopkins University | 70 | 2022-02-17 | 2026-08-03 |
| Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study Placebo, Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg, Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 1 | Completed | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 10 | 2021-11-09 | 2023-10-26 |
| The Behavioral Effects of Opioids and Alcohol Alcohol, Opioid Agonist - Opioid Use, Alcohol Drinking | Phase 1 | Completed | Sharon Walsh | 11 | 2021-03-24 | 2025-11-20 |
| Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk Behaviors Alcohol beverage, Placebo beverage - Alcohol Consumption | Phase 1 | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 20 | 2021-03-18 | 2026-10-26 |
| Strengths-based Linkage to Alcohol Care (SLAC) for Hazardous Drinkers in Primary Care Strengths-based linkage to alcohol care, Usual care - Alcohol-induced Disorders, Alcohol Drinking | Phase 1 | Completed | VA Office of Research and Development | 140 | 2021-01-01 | 2026-01-13 |
| A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants Reference Treatment- BMS-986165-01, Prototype BMS-986165, Famotidine - Healthy Volunteers | Phase 1 | Completed | Bristol-Myers Squibb | 56 | 2020-09-10 | 2021-10-06 |
| Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies Alcohol Moderation Mobile Application, Alcohol Moderation Drink Tracker - Alcohol Abuse, Alcohol Use Disorder | Phase 1 / Phase 2 | Completed | Kent State University | 64 | 2020-02-05 | 2024-11-18 |
| A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects ASP8062, Alcohol, ASP8062 Placebo - Healthy Volunteers | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 20 | 2019-07-16 | 2024-11-05 |
| Marijuana Effects on Simulated Driving Performance Marijuana, Alcohol, placebo alcohol - Cannabis, Cannabis Use | Phase 1 | Completed | Shanna Babalonis, PhD | 10 | 2019-07-01 | 2024-07-31 |
| The Alcohol-Pain Connection: Mechanisms and Genetic/Psychological Correlates Low Alcohol, Moderate Alcohol, Placebo Alcohol - Pain, Alcohol Drinking | Phase 1 | Completed | Syracuse University | 379 | 2019-05-12 | 2022-08-17 |
| A Study Comparing Two Topicals in the Treatment of Acne Vulgaris FMX101 vehicle, Hydro-alcohol solution - Acne Vulgaris | Phase 1 | Completed | Vyne Therapeutics Inc. | 12 | 2018-11-20 | 2021-04-06 |
| Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate) Alcohol, Placebos, Duloxetine (60 MG) - Alcohol Use Disorder | Phase 1 | Completed | Craig Rush | 19 | 2018-09-01 | 2026-06-09 |
| Evaluation of Bioavailability and Metabolism of Diet Phenolic Compounds Administration of olive oil, Administration of red wine, Combination of red wine and olive oil - Healthy | Phase 1 | Completed | Parc de Salut Mar | 20 | 2018-07-09 | 2020-03-05 |
| Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2 Aluminum Chloride 20% (deodorant), Alcohol - Hyperhidrosis | Phase 1 | Completed | University of Utah | 95 | 2018-05-08 | 2022-10-17 |
| Study of Lemborexant-Alcohol Interaction in Healthy Subjects Lemborexant, Alcohol, Placebo - Healthy Subjects | Phase 1 | Completed | Eisai Inc. | 24 | 2018-03-12 | 2018-10-17 |
| Percutaneous Ethanol Injection for Benign Cystic Thyroid Nodules ethanol injection - Thyroid Nodule | Phase 1 | Completed | hassan harby mohamed | 1 | 2017-08-11 | 2020-05-15 |
| Thirdhand Smoke Contamination in a Neonatal Intensive Care Unit (NICU) 2% Chlorohexidine Gluconate soap, 62% ethyl alcohol-based hand sanitizer - Nicotine Exposure | Phase 1 | Completed | The University of Texas Health Science Center, Houston | 14 | 2017-06-07 | 2022-05-09 |
Showing 20 of 70. Sign in to see all of them.
Alcohol Drinking (10) · Alcoholism (9) · Erectile Dysfunction (4) · Alcohol-Related Disorders (3) · Alcoholic Intoxication (3) · Marijuana Abuse (2) · Stress Disorders, Post-Traumatic (2) · Substance-Related Disorders (2) · Surgical Wound Infection (2) · Acne Vulgaris (1) · Acute Pain (1) · Alcohol Drinking in College (1) · Alcohol-Induced Disorders (1) · Amphetamine-Related Disorders (1) · Binge-Eating Disorder (1)
Parc de Salut Mar (7) · Johns Hopkins University (3) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (3) · Yale University (3) · Syracuse University (2) · Universidade do Porto (2) · VA Office of Research and Development (2) · Abby Braitman (1) · Actavis Inc. (1) · American Medical Systems (1) · Asan Medical Center (1) · Astellas Pharma Global Development, Inc. (1) · Boehringer Ingelheim (1) · Bristol-Myers Squibb (1) · Centre for Addiction and Mental Health (1)
United States (39) · Spain (7) · Canada (3) · Netherlands (3) · China (2) · Kenya (2) · Portugal (2) · United Kingdom (2) · Egypt (1) · France (1) · South Korea (1) · Taiwan (1)
Roland R Griffiths, Ph.D. (2) · Abby L Braitman, Ph.D. (1) · Ahad Sabet, MD (1) · Alawia Suliman, MD (1) · Aziz Laurent, MD (1) · Benjamin A. Toll, Ph.D. (1) · Bernard Le Foll, MD, PhD (1) · Brian E. Borsari, PhD (1) · Chen Yu (1) · Colby Hansen, MD (1)
PMID 11803175, PMID 12166794, PMID 12509548, PMID 17574344, PMID 18201934, PMID 18612578, PMID 18781243, PMID 20116962, PMID 20878941, PMID 21193284, PMID 22297835, PMID 22924334, PMID 23154216, PMID 24512944, PMID 25419583, PMID 25724154, PMID 25801942, PMID 26098125, PMID 26099520, PMID 26240742, PMID 26402350, PMID 26460571, PMID 27936818, PMID 28774194, PMID 30735255, PMID 32063845, PMID 32757149, PMID 34338762, PMID 34634832, PMID 35212235, PMID 36001429, PMID 36480413, PMID 37592359, PMID 38100057, PMID 38152462, PMID 42065887
2016 (1), F32AA021310 (1), K99AA025401 (1), P30CA008748 (1), R01AA022301 (1), R01AA024844 (1), R01AA026255 (1), R01CA140256 (1), R01DA003890 (1), R01DA016718 (1), R01DA052295 (1), R03HD088847 (1), R21AA017291 (1), R21AA025277 (1), R21DA045101 (1)